Systaaq Diagnostic Products

07/07/2020

We are pleased to Introduce Multigene COVID-19 real time PCR kit, for more details please visit our website.

https://www.systaaq.com/product/covid-19/

06/14/2020

http://www.pwcecondev.org/systaaq-diagnostic

03/16/2020

Really appreciate the efforts of our production team working with to deliver products in time.

03/14/2020

https://www.cnet.com/news/coronavirus-testing-will-be-free-for-all-americans-cdc-director-says/

The commitment comes during a back-and-forth with a member of Congress who pointed out the high costs associated with testing.

03/13/2020

https://www.foxnews.com/opinion/dr-robert-siegel-coronavirus-response-requires-several-hundred-million-test-kits-a-massive-increase

Hundreds of millions of coronavirus test kits need to be distributed to U.S. medical facilities and to other countries as well.

03/09/2020

SYSTAAQ Diagnostics is Please to Launch Real Time PCR kit. The Kits are available for immediate shipment.

The assay has been developed in guidance of Centers for Disease Control and Prevention, Respiratory Viruses Branch, Division of Viral Diseases - USA following WHO Interim Guidelines.

For more Information please contact us: info@systaaq.com

01/22/2019

HBV Real TIme PCR Assay CE-Marked

01/22/2019

https://www.genomeweb.com/molecular-diagnostics/systaaq-hbv-assay-receives-ce-mark #.XEdDmVUzbIU

The assay is designed to quantitate HBV DNA in serum or plasma to assist in the treatment of chronic HBV-infected patients receiving antiviral therapy.

11/20/2018

visit out booth at MEDLAB - Dubai

11/19/2018

We operate a state of the art molecular facility at Manassas, Virginia (USA) with a team of scientists dedicated to the best practices in quality and design control. Molecular products are manufactured under good manufacturing practices (GMP) and ISO 13485 Certification. A variety of product labeling standards, including RUO, ASR, CE and IVD, are developed and released under the appropriate design control process and launched as per any country’s specific regulatory requirements.